Furthermore, the CNS5 classification incorporates molecular markers such as IDH mutation status, 1p/19q codeletion, and MGMT promoter methylation status to provide a more precise classification of gliomas [9,10]. The gene discussed is IDH1; the disease is central nervous system cancer.